Literature DB >> 26412395

Influenza virus survival in aerosols and estimates of viable virus loss resulting from aerosolization and air-sampling.

J R Brown1, J W Tang2, L Pankhurst3, N Klein4, V Gant5, K M Lai6, J McCauley7, J Breuer4.   

Abstract

Using a Collison nebulizer, aerosols of influenza (A/Udorn/307/72 H3N2) were generated within a controlled experimental chamber, from known starting virus concentrations. Air samples collected after variable suspension times were tested quantitatively using both plaque and polymerase chain reaction assays, to compare the proportion of viable virus against the amount of detectable viral RNA. These experiments showed that whereas influenza RNA copies were well preserved, the number of viable viruses decreased by a factor of 10(4)-10(5). This suggests that air-sampling studies for assessing infection control risks that detect only influenza RNA may greatly overestimate the amount of viable virus available to cause infection.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Air-sampling; Airborne; Infection; Influenza; Nebulizer; Transmission

Mesh:

Substances:

Year:  2015        PMID: 26412395     DOI: 10.1016/j.jhin.2015.08.004

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  14 in total

1.  Utility of Three Nebulizers in Investigating the Infectivity of Airborne Viruses.

Authors:  Sadegh Niazi; Lisa K Philp; Kirsten Spann; Graham R Johnson
Journal:  Appl Environ Microbiol       Date:  2021-07-27       Impact factor: 4.792

2.  Sampling and detection of airborne influenza virus towards point-of-care applications.

Authors:  Laila Ladhani; Gaspard Pardon; Hanne Meeuws; Liesbeth van Wesenbeeck; Kristiane Schmidt; Lieven Stuyver; Wouter van der Wijngaart
Journal:  PLoS One       Date:  2017-03-28       Impact factor: 3.240

3.  [Position Paper for the State of the Art Application of Respiratory Support in Patients with COVID-19 - German Respiratory Society].

Authors:  M Pfeifer; S Ewig; T Voshaar; W Randerath; T Bauer; J Geiseler; D Dellweg; M Westhoff; W Windisch; B Schönhofer; S Kluge; P M Lepper
Journal:  Pneumologie       Date:  2020-04-22

4.  [Management of diagnostic procedures and treatment of sleep related breathing disorders in the context of the coronavirus pandemic].

Authors:  N Büchner; H Woehrle; D Dellweg; A Wiater; P Young; H Hein; W Randerath
Journal:  Somnologie (Berl)       Date:  2020-06-22

5.  Airborne Influenza A Virus Exposure in an Elementary School.

Authors:  Kristen K Coleman; William V Sigler
Journal:  Sci Rep       Date:  2020-02-05       Impact factor: 4.379

Review 6.  Generic aspects of the airborne spread of human pathogens indoors and emerging air decontamination technologies.

Authors:  M Khalid Ijaz; Bahram Zargar; Kathryn E Wright; Joseph R Rubino; Syed A Sattar
Journal:  Am J Infect Control       Date:  2016-09-02       Impact factor: 2.918

7.  Nebulisers as a potential source of airborne virus.

Authors:  Julian W Tang; Petri Kalliomaki; Taru M Varila; Matti Waris; Hannu Koskela
Journal:  J Infect       Date:  2020-05-15       Impact factor: 6.072

8.  On the airborne transmission of SARS-CoV-2 and relationship with indoor conditions at a hospital.

Authors:  Zeynab Baboli; Niloofar Neisi; Ali Akbar Babaei; Mehdi Ahmadi; Armin Sorooshian; Yaser Tahmasebi Birgani; Gholamreza Goudarzi
Journal:  Atmos Environ (1994)       Date:  2021-06-21       Impact factor: 4.798

9.  Influenza virus RNA recovered from droplets and droplet nuclei emitted by adults in an acute care setting.

Authors:  Lily Yip; Mairead Finn; Andrea Granados; Karren Prost; Allison McGeer; Jonathan B Gubbay; James Scott; Samira Mubareka
Journal:  J Occup Environ Hyg       Date:  2019-05-03       Impact factor: 2.155

10.  Use of medical face masks versus particulate respirators as a component of personal protective equipment for health care workers in the context of the COVID-19 pandemic.

Authors:  John Conly; W H Seto; Didier Pittet; Alison Holmes; May Chu; Paul R Hunter
Journal:  Antimicrob Resist Infect Control       Date:  2020-08-06       Impact factor: 4.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.